Variant · Other
TAP2 NM_001290043.2(TAP2):c.1144-16_1144-13del
CI-VAR-00196146Explore in graph →NM_001290043.2:c.1144-16_1144-13delClinVar 1164355 rs200922606
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-06
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260908-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 1164355 | Benign | criteria provided, multiple submitters, no conflicts | 2 | MHC class I deficiency; Chronic lymphocytic leukemia/small lymphocytic lymphoma; Nonpapillary renal cell carcinoma | germline | 3 | Jan 29, 2026 | clinvar |